Thermo Fisher Scientific Inc. (TMO) reached the 52-week high of $152.69
The company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It serves customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial quality and process control settings. The company's continuing operations fall into three business segments: analytical technologies, specialty diagnostics, and laboratory products and services.
The prices of Thermo Fisher Scientific shares have reached $152.69, which is 1.4% off the 52-week high of $154.81. Thermo Fisher Scientific has a market cap of $60.09 billion; its shares were traded around $152.69 with a P/E ratio of 30.80 and P/S ratio of 3.51. The trailing 12-month dividend yield of Thermo Fisher Scientific stocks is 0.39%. The forward dividend yield of Thermo Fisher Scientific stocks is 0.39%. Thermo Fisher Scientific had an annual average earnings growth of 14.80% over the past 10 years. GuruFocus rated Thermo Fisher Scientific the business predictability rank of 5-star .
For the first quarter of 2016, the company has reported that adjusted EPS grew 10% to $1.80, versus $1.63 in the first quarter of 2015. Revenue for the quarter also grew 10% to $4.29 billion in 2016, versus $3.92 billion in 2015.
CEO Marc N Casper sold 20,000 shares of TMO stock on July 5 at the average price of $147.69. The price of the stock has increased by 3.39% since.
Goldman Sachs Group Inc. (NYSE:GSPRN) reached the 52-week high of $27.35
The company is an investment banking, securities and investment management firm that provides a range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals. The company's activities are divided into four segments: investment banking, institutional client services, investing & lending and investment management.
The prices of Goldman Sachs Group shares have reached $27.35, which is 0.2% off the 52-week high of $27.40. Goldman Sachs Group has a market cap of $11.36 billion; its shares were traded around $27.35 with a P/E ratio of 16.30 and P/S ratio of 2.23. Goldman Sachs Group had an annual average earnings growth of 0.10% over the past 10 years.
The company recently reported net revenues of $6.34 billion and net earnings of $1.14 billion for the first quarter ended March 31. Diluted earnings per common share were $2.68 compared with $5.94 for the first quarter of 2015 and $1.27 for the fourth quarter of 2015.
Stanley Black & Decker Inc. (SWK) reached the 52-week high of $114.97
The company is a diversified provider of hand tools, power tools and related accessories, mechanical access solutions (i.e. automatic doors and commercial locking systems), electronic security and monitoring systems, healthcare solutions, engineered fastening systems and products and services for various industrial applications. It operates in three segments including Tools & Storage, Security and Industrial.
The prices of Stanley Black & Decker shares have reached $114.97, which is 0.3% off the 52-week high of $115.36. Stanley Black & Decker has a market cap of $17.26 billion; its shares were traded around $114.97 with a P/E ratio of 19.00 and P/S ratio of 1.54. The trailing 12-month dividend yield of Stanley Black & Decker stocks is 1.91%. The forward dividend yield of Stanley Black & Decker stocks is 1.91%. Stanley Black & Decker had an annual average earnings growth of 4.70% over the past 10 years.
The company has reported that revenues for the first quarter of 2016 totaled $2.7 billion, up 2% versus prior year, and that first quarter diluted EPS was $1.28, up 20% from last year.
Delhaize Group SA (DEG) reached the 52-week high of $27.45
Delhaize Group operates food supermarkets. It conducts its retail operations through its businesses in the U.S.; Belgium and the Grand Duchy of Luxembourg, collectively as Delhaize Belgium; Greece, Romania and Serbia, collectively as Southeastern Europe; and Indonesia. Its store network also includes other store formats such as proximity, cash and carry and specialty stores.
The prices of Delhaize Group shares have reached $27.45, which is 0.4% off the 52-week high of $27.55. Delhaize Group has a market cap of $11.39 billion; its shares were traded around $27.45 with a P/E ratio of 23.05 and P/S ratio of 0.42. The trailing 12-month dividend yield of Delhaize Group stocks is 1.83%. The forward dividend yield of Delhaize Group stocks is 1.83%.
The company has reported that in the first quarter of 2016, Delhaize Group's revenue from across the world was a little more than EUR6.15 billion (or around $6.8 billion) which was an increase of 5.7% from last year. Also, group share in net profit amounted to EUR109 million compared to EUR28 million last year.
C.R. Bard Inc. (BCR) reached the 52-week high of $239.00
C.R. Bard is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. The company participates in the markets for vascular, urology, oncology and surgical specialty products. It reports its sales in four product group categories: vascular, urology, oncology and surgical specialties.
The prices of C.R. Bard shares have reached $239.00, which is 0.1% off the 52-week high of $239.34. CR Bard has a market cap of $17.52 billion; its shares were traded around $239.00 with a P/E ratio of 168.28 and P/S ratio of 5.16. The trailing 12-month dividend yield of the stock is 0.40%. The forward dividend yield of stock is 0.44%. CR Bard had an annual average earnings growth of 8.90% over the past 10 years. GuruFocus rated CR Bard the business predictability rank of 2-star .
The company recently reported that first quarter 2016 net sales were $873.5 million, an increase of 7% over the prior-year period on an as-reported basis. Meanwhile, net income was $116.2 million and diluted earnings per share were $1.54, a decrease of 17% and 15%, respectively, as compared to first quarter 2015 results.
Note: I do not own these stocks.
Start a free 7-day trial of Premium Membership to GuruFocus.
